Abstract:Background: Intraamniotic inflammation is associated with preterm birth, especially in cases occurring before 32 weeks' gestation, and is causally linked with an increased risk for neonatal mortality and morbidity. Targeted anti-inflammatory interventions may assist in improving the outcomes for pregnancies impacted by intrauterine inflammation. Interleukin-1 is a central upstream mediator of inflammation. Accordingly, interleukin-1 is a promising candidate target for intervention therapies and has been targeted previously using the interleukin-1 receptor antagonist, anakinra. Recent studies have shown that the novel, noncompetitive, allosteric interleukin-1 receptor inhibitor, rytvela, partially resolved inflammation associated with preterm birth and fetal injury. In this study, we used a preterm sheep model of chorioamnionitis to investigate the anti-inflammatory efficacy of rytvela and anakinra, administered in the amniotic fluid in the setting of intraamniotic Escherichia coli lipopolysaccharide exposure. Objective: We hypothesized that both rytvela and anakinra would reduce lipopolysaccharide-induced intrauterine inflammation and protect the fetal brain. Study design: Ewes with a singleton fetus at 105 days of gestation (term is ∼150 days) were randomized to one of the following groups: (1) intraamniotic injections of 2 mL saline at time=0 and time=24 hours as a negative control group (saline group, n=12); (2) intraamniotic injection of 10 mg Escherichia coli lipopolysaccharide in 2 mL saline and intraamniotic injections of 2 mL saline at time=0 hours and time=24 hours as an inflammation positive control group (lipopolysaccharide group, n=11); (3) intraamniotic injection of Escherichia coli lipopolysaccharide in 2 mL saline and intraamniotic injections of 2.5 mg rytvela at time=0 hours and time=24 hours to test the anti-inflammatory efficacy of rytvela (lipopolysaccharide + rytvela group, n=10); or (4) intraamniotic injection of Escherichia coli lipopolysaccharide in 2 mL saline and intraamniotic injections of 100 mg anakinra at time=0 hours and time=24 hours to test the anti-inflammatory efficacy of anakinra (lipopolysaccharide + anakinra group, n=12). Amniotic fluid was sampled at time 0, 24, and 48 hours (ie, at each intervention and at delivery). Fetal umbilical cord blood was collected at delivery for differential blood counts and chemical studies. Inflammation was characterized by the analysis of fetal tissue cytokine and chemokine levels using quantitative polymerase chain reaction, enzyme-linked inmmunosorbent assay, and histology. The primary study outcome of interest was the assessment of anakinra and rytvela brain-protective effects in the setting of Escherichia coli lipopolysaccharide-induced intrauterine inflammation. Secondary outcomes of interest were to assess protection from fetal and intrauterine (ie, amniotic fluid, chorioamnion) inflammation. Results: Intraamniotic administration of lipopolysaccharide caused inflammation of the fetal lung, brain, and chorioamnionitis in preterm fetal sheep. Relative to treatment with saline only in the setting of lipopolysaccharide exposure, intraamniotic administration of both rytvela and anakinra both significantly prevented periventricular white matter injury, microglial activation, and histologic chorioamnionitis. Anakinra showed additional efficacy in inhibiting fetal lung myeloperoxidase activity, but its use was associated with metabolic acidaemia and reduced fetal plasma insulin-like growth factor-1 levels at delivery. Conclusion: Intraamniotic administration of rytvela or anakinra significantly inhibited fetal brain inflammation and chorioamnionitis in preterm fetal sheep exposed to intraamniotic lipopolysaccharide. In addition, anakinra treatment was associated with potential negative impacts on the developing fetus.

ASSA13-303-4 Study of Brain Injuries Induced by Intrauterine Balloon Aortic Valvuloplasty and Protective Evaluation Indomethacin of on Fetal Lamb Model

Hemodynamic and Growth Effect of Indomethacin on Fetal Goat Model of Intrauterine Balloon Aortic Valvuloplasty

Protective Effects of Indomethacin and Dexamethasone in a Goat Model with Intrauterine Balloon Aortic Valvuloplasty

Impact of Intrauterine Balloon Aortic Valvuloplasty on Gestational Outcome in A Fetal Goat Model

Protective Effect of Dexamethasone on Stress Response Induced by Intrauterine Balloon Aortic Valvuloplasty in a Fetal Lamb Model

Fetal Pulmonary Vascular Remodeling in A Rat Model Induced by Hypoxia and Indomethacin

Intra-utero fetal cardiac intervention in medium and late pregnancy stages in the fetal lamb

Diffusion Tensor Imaging Colour Mapping Threshold for Identification of Ventilation-Induced Brain Injury after Intrauterine Inflammation in Preterm Lambs

Study on anesthesia protocols for pregnant goat during intrauterine cardiac intervention for the fetus

Intrauterine inflammation and postnatal intravenous dopamine alter the neurovascular unit in preterm newborn lambs

The synergistic effects of mechanical ventilation and intrauterine inflammation on cerebral inflammation in preterm fetal sheep

Studies on Catheterization of Fetal Arteria Mbilicalis Uterus of Pregant Sheep

Pharmacological blockade of the interleukin-1 receptor suppressed Escherichia coli lipopolysaccharide-induced neuroinflammation in preterm fetal sheep

Ischemia/Reperfusion-induced neovascularization in the cerebral cortex of the ovine fetus

[An Experimental Study on the Treatment of Fetal Rabbits with Intrauterine Growth Retardation].

The alterations of cardiac function during venovenous artificial placenta support in fetal goats

[The Research of Animal Model Setting-Up in Human Intra-Utero Fetal Cardiac Intervention].

The Changes of Blood Gas and the Concentration of Inflammatory Cytokines During the Intrauterine Cardiac Intervention Surgery

Establishment of intrauterine hypoxic-ischemic brain damage model in near term fetal rabbits

In utero ventilation induces lung parenchymal and vascular alterations in extremely preterm fetal sheep

OS047. Quantification of placental vascularization in a rabbit model ofIUGR with three-dimensional power doppler angiography